Intelligent Bio Solutions to Implement 1-for-10 Reverse Split; Shares Fall
AI Sentiment
Negative
2/10
as of 12-12-2025 3:33pm EST
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
| Founded: | 2016 | Country: | United States |
| Employees: | 55 | City: | NEW YORK |
| Market Cap: | 5.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 148.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.68 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.56 - $2.75 | Next Earning Date: | 11-12-2025 |
| Revenue: | $3,292,042 | Revenue Growth: | 3.26% |
| Revenue Growth (this year): | 778.48% | Revenue Growth (next year): | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
INBS Breaking Stock News: Dive into INBS Ticker-Specific Updates for Smart Investing
AI Sentiment
Negative
2/10
AI Sentiment
Neutral
4/10
See how INBS stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "INBS Intelligent Bio Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.